Similar Papers

Paper Title
Journal
Date
Author
TP53 Variant Allele Frequency and Therapy-Related Setting Independently Predict Survival in Myelodysplastic Syndromes with Del(5q)
Farah Fleti ... Kaaren K Reichard
Blood | VOL. 142
Farah Fleti, et. al.Farah Fleti ... Kaaren K Reichard
28 Nov 2023
Genomic Context and TP53 Allele Frequency Define Prognostic Subgroups and Response Outcomes in TP53 Mutated Myelodysplastic Syndromes
...
Blood | VOL. 134
, et. al. ...
13 Nov 2019
Prognostic Discrimination within a Heterogeneous Population of TP53-Aberrant Myelodysplastic Syndromes and Acute Myeloid Leukemia
Shyam A Patel ... Jonathan M Gerber
Blood | VOL. 140
Shyam A Patel, et. al.Shyam A Patel ... Jonathan M Gerber
15 Nov 2022
Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†☆
P Fenaux ... U Mey
Annals of Oncology | VOL. 32
P Fenaux, et. al.P Fenaux ... U Mey
19 Nov 2020
View more papers

More From: American journal of hematology

Paper Title
Journal
Date
Author
Elderly Patients With Aplastic Anemia: Treatment Patterns and Outcomes in the Real World.
Bruno Fattizzo ... Wilma Barcellini
American journal of hematology | VOL. -
Bruno Fattizzo, et. al.Bruno Fattizzo ... Wilma Barcellini
29 Jan 2025
Chronic Lymphocytic Leukemia: 2025 Update on the Epidemiology, Pathogenesis, Diagnosis, and Therapy.
Michael Hallek
American journal of hematology | VOL. -
Michael HallekMichael Hallek
28 Jan 2025
Prospective Pharmacokinetic Evaluation of Venetoclax in AML Supports Re-Evaluation of Recommended Dose Adjustments With Azole Antifungals.
Jitesh D Kawedia ... Tapan M Kadia
American journal of hematology | VOL. -
Jitesh D Kawedia, et. al.Jitesh D Kawedia ... Tapan M Kadia
28 Jan 2025
TP53 Mutations in Myeloproliferative Neoplasms: Context-Dependent Evaluation of Prognostic Relevance.
Ayalew Tefferi ... Paola Guglielmelli
American journal of hematology | VOL. -
Ayalew Tefferi, et. al.Ayalew Tefferi ... Paola Guglielmelli
28 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.